Wealthfront Advisers LLC acquired a new position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 32,939 shares of the company's stock, valued at approximately $1,306,000.
A number of other large investors have also modified their holdings of the company. Nisa Investment Advisors LLC increased its holdings in shares of Acadia Healthcare by 40.7% in the 4th quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company's stock worth $41,000 after acquiring an additional 301 shares during the period. Atria Investments Inc increased its holdings in shares of Acadia Healthcare by 4.7% in the 3rd quarter. Atria Investments Inc now owns 6,844 shares of the company's stock worth $434,000 after acquiring an additional 308 shares during the period. Pacer Advisors Inc. increased its holdings in shares of Acadia Healthcare by 2.4% in the 4th quarter. Pacer Advisors Inc. now owns 13,847 shares of the company's stock worth $549,000 after acquiring an additional 325 shares during the period. KBC Group NV increased its holdings in shares of Acadia Healthcare by 14.4% in the 3rd quarter. KBC Group NV now owns 2,688 shares of the company's stock worth $170,000 after acquiring an additional 338 shares during the period. Finally, Tidal Investments LLC increased its holdings in shares of Acadia Healthcare by 7.9% in the 3rd quarter. Tidal Investments LLC now owns 4,664 shares of the company's stock worth $296,000 after acquiring an additional 340 shares during the period.
Analyst Ratings Changes
ACHC has been the subject of a number of recent analyst reports. Cantor Fitzgerald reiterated a "neutral" rating and issued a $52.00 target price on shares of Acadia Healthcare in a research report on Tuesday, December 10th. Royal Bank of Canada decreased their target price on shares of Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating for the company in a research report on Monday, March 3rd. Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a "hold" rating to a "buy" rating and increased their target price for the company from $45.00 to $75.00 in a research report on Thursday, December 12th. KeyCorp decreased their target price on shares of Acadia Healthcare from $70.00 to $65.00 and set an "overweight" rating for the company in a research report on Monday, March 3rd. Finally, Bank of America reduced their price objective on shares of Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating for the company in a research report on Friday, February 28th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and five have given a buy rating to the company's stock. According to data from MarketBeat.com, Acadia Healthcare has an average rating of "Hold" and an average price target of $56.31.
Get Our Latest Research Report on ACHC
Acadia Healthcare Trading Up 0.4 %
Shares of ACHC traded up $0.12 during midday trading on Wednesday, hitting $29.26. The stock had a trading volume of 1,660,281 shares, compared to its average volume of 1,318,839. Acadia Healthcare Company, Inc. has a fifty-two week low of $27.61 and a fifty-two week high of $82.41. The business has a 50-day simple moving average of $39.52 and a two-hundred day simple moving average of $47.57. The firm has a market cap of $2.72 billion, a P/E ratio of 9.59, a price-to-earnings-growth ratio of 1.46 and a beta of 1.38. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60.
About Acadia Healthcare
(
Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Stories

Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.